Philip R. Hagerman co-founded Diplomat Specialty Pharmacy with his father, Dale Hagerman in 1975. Diplomat grew to be the nation’s largest independent specialty pharmacy with revenue growing from $25 million in 2005 to over $4 Billion in 2015, recognized as one of the fastest-growing companies in healthcare, and became a publicly-traded company through its IPO on the NYSE in October 2014.
Mr. Hagerman led Diplomat as its CEO and Chairman of the Board of Directors for 27 years. He has a unique perspective and understanding of the business, culture, and history, having led Diplomat through many economic cycles and operational initiatives. His day-to-day leadership of Diplomat gives him critical insights into operations, strategy, and competition in broad areas of healthcare and business.
Throughout his career at Diplomat, he has demonstrated strong entrepreneurial skills, as well as regulatory, marketing, strategic, and operational expertise. Mr. Hagerman also possesses in-depth knowledge of, and key relationships in healthcare and the specialty pharmacy industry on a national basis.
Mr. Hagerman founded SkyPoint Ventures in 2013 and remains its CEO. SkyPoint Ventures is a real estate and venture investment firm, headquartered in Flint, Michigan. SkyPoint Ventures focuses on early-stage companies in multiple disciplines and engaging the entrepreneurial spirit while developing industry-leading processes and technology.
Mr. Hagerman currently serves as CEO of Forum Health Enterprises, Inc. Forum Health, founded in February 2019, focuses on building a network of integrative and functional medical practices across the nation and includes a nutraceutical division, Inwell Biosciences, and a technology division – Power2Practice.
Inwell has created a line of proprietary supplements specific to the needs of physicians in Integrative and Functional medicine. Power2Practice is an EMR and practice management software system created specifically for integrative medical practices, used by over 1000 practitioners nationwide.
